Additionally, while NPM, FLT3-ITD and DNMT3A mutations rarely co-occur in AML, they interact to drive the increased expression of the transcription factor hepatic leukemia factor (HLF) [49]. The gene discussed is NPM1; the disease is acute myeloid leukemia.